Physiomics Plc (AIM:PYC)
London
· Delayed Price · Currency is GBP · Price in GBX 0.441
-0.009 (-2.00%)
Mar 6, 2026, 11:03 AM GMT
Physiomics Revenue
Physiomics had revenue of 528.00K GBP in the half year ending December 31, 2025, with 38.22% growth. This brings the company's revenue in the last twelve months to 1.01M, up 85.81% year-over-year. In the fiscal year ending June 30, 2025, Physiomics had annual revenue of 834.16K with 46.20% growth.
Revenue (ttm)
1.01M
Revenue Growth
+85.81%
P/S Ratio
1.35
Revenue / Employee
100.82K
Employees
10
Market Cap
1.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 834.16K | 263.60K | 46.20% |
| Jun 30, 2024 | 570.56K | -35.17K | -5.81% |
| Jun 30, 2023 | 605.73K | -294.97K | -32.75% |
| Jun 30, 2022 | 900.71K | 169.81K | 23.23% |
| Jun 30, 2021 | 730.90K | -110.75K | -13.16% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ValiRx | 49.78K |
| OptiBiotix Health | 1.15M |
| CRISM Therapeutics | 25.00K |
| Futura Medical | 7.93M |
| IXICO | 6.53M |
| Oxford BioDynamics | 1.10M |
Physiomics News
- 4 weeks ago - AIM Market Roundup: Physiomics, Harvest Minerals, Blue Star Capital - The Armchair Trader
- 3 months ago - AIM Market Roundup: Genincode, Proteome Sciences, Caspian Sunrise - The Armchair Trader
- 5 months ago - Full Year 2025 Physiomics PLC Investor Presentation Transcript - GuruFocus
- 1 year ago - AIM Market Roundup: Future Metals, Eurasia Mining, Blackbird - The Armchair Trader